Talen Energy Corp
For the period ended Jun 30, 2026. Filed Aug 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 5, 2026
TLN$361.18-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Six Months Ended June 30, | ||
|---|---|---|
| (Millions of Dollars) | 2026 | 2025 |
| Operating Activities | ||
| Net Income (Loss) | $(29) | $(63) |
| Non-cash reconciliation adjustments: | ||
| Unrealized (gains) losses on derivative instruments (Note 2) | 352 | 103 |
| Depreciation, amortization and accretion (Note 16) | 158 | 141 |
| Nuclear decommissioning trust funds (gain) loss, net (excluding interest and fees) (Note 6) | (85) | (44) |
| Nuclear fuel amortization (Note 7) | 46 | 44 |
| Deferred income taxes | (34) | (66) |
| Stock-based compensation (Note 13) | 69 | 27 |
| Other (Note 16) | 35 | 7 |
| Changes in assets and liabilities: | ||
| Accounts receivable | (59) | (103) |
| Inventory, net | 10 | 78 |
| Other assets | 14 | 15 |
| Accounts payable and accrued liabilities | 20 | (57) |
| Accrued interest | 107 | 12 |
| Collateral received (posted), net | (35) | (58) |
| Cash settlement of stock-based awards (Note 13) | (495) | — |
| Other liabilities | (47) | (101) |
| Net cash provided by (used in) operating activities | 27 | (65) |
| Investing Activities | ||
| Property, plant and equipment expenditures (Note 7) | (181) | (51) |
| Nuclear fuel expenditures (Note 7) | (66) | (50) |
| Nuclear decommissioning trust funds investment purchases (Note 6) | (195) | (1,201) |
| Nuclear decommissioning trust funds investment sale proceeds (Note 6) | 173 | 1,186 |
| Cornerstone Acquisition, net (Note 17) | (2,568) | — |
| Other | 13 | 2 |
| Net cash provided by (used in) investing activities | (2,824) | (114) |
| Financing Activities | ||
| Debt issuances (Note 10) | 4,000 | — |
| Debt repayments (Note 10) | (1,215) | (9) |
| Deferred financing costs | (58) | (9) |
| Revolving credit facility borrowings (Note 10) | 500 | 75 |
| Revolving credit facility repayments (Note 10) | (500) | (5) |
| Share repurchases (Note 15) | (298) | (103) |
| Tax payments related to net-settled stock-based awards (Note 13) | (140) | — |
| Other | (6) | — |
| Net cash provided by (used in) financing activities | 2,283 | (51) |
| Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents | (514) | (230) |
| Beginning of period cash and cash equivalents and restricted cash and cash equivalents | 752 | 365 |
| End of period cash and cash equivalents and restricted cash and cash equivalents | $238 | $135 |
See Note 16 for supplemental cash flow information.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.